Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia.

MLA

Theodore, Deborah A., et al. “Initial Micafungin Treatment Does Not Improve Outcomes Compared to Fluconazole Treatment in Immunocompromised and Critically Ill Patients with Candidaemia.” Journal of Antimicrobial Chemotherapy (JAC), vol. 79, no. 8, Aug. 2024, pp. 1877–84. EBSCOhost, https://doi.org/10.1093/jac/dkae175.

APA

Theodore, D. A., Henneman, A. D., Loo, A., Shields, R. K., Eschenauer, G., Sobieszczyk, M. E., & Kubin, C. J. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy (JAC), 79(8), 1877–1884. https://doi.org/10.1093/jac/dkae175

Chicago

Theodore, Deborah A, Amrita D Henneman, Angela Loo, Ryan K Shields, Gregory Eschenauer, Magdalena E Sobieszczyk, and Christine J Kubin. 2024. “Initial Micafungin Treatment Does Not Improve Outcomes Compared to Fluconazole Treatment in Immunocompromised and Critically Ill Patients with Candidaemia.” Journal of Antimicrobial Chemotherapy (JAC) 79 (8): 1877–84. doi:10.1093/jac/dkae175.